Safety Profile of the Combination of Levosimendan and IV Beta Blocker in Cardiogenic Shock: a Retrospective Study (SeLeBêta)

Central Hospital, Nancy, France

Status: Unknown

Conditions: Arrythmia; Cardiogenic Shock

Study type: Observational

Funder types: Other

Identifiers

NCT04938375

2021PI069

Details and patient eligibility

About

The purpose of this study is to assess the safety profile of the combination of Levosimendan and beta blocker in cardiogenic shock with arrythmia.

Enrollment: 25 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients admitted to the ICU for cardiogenic shock who received esmolol or landiolol within 7 days of a levosimendan treatment

Exclusion criteria

• Patient's opposition